Latest Northwest Biotherapeutics Stories
Funding Includes $25 Million Equity Investment By Leading UK Investment Fund and $10 Million Mortgage Financing BETHESDA, Md., Nov.
BETHESDA, Md., Nov. 7, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
Financing From Single Existing Institutional Shareholder BETHESDA, Md., Oct.
"PIM" Designation For DCVax-L Is First Step In 2-Step Process for Early Access Approval BETHESDA, Md., Sept.
BETHESDA, Md., Sept. 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
BETHESDA, Md., Sept.
Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug.
Convertible at $7.30 Per Share; Will Fund New Manufacturing Capacity in Europe BETHESDA, Md., Aug. 14, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
NEW YORK, July 9, 2014 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Northwest Biotherapeutics, Inc.
All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/
- Sleep; the state or condition of being asleep.